NCT01871285 - Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Pain

Interventions

DRUG

Buprenorphine

DRUG

Placebo film

Matching placebo buccal film

DRUG

Oxycodone

Oxycodone extended-release (ER) or immediate-release (IR) 5, 10, 15, 20, and 30 mg over-encapsulated oral tablets

DRUG

Morphine sulfate

Morphine sulfate 15, 30, and 60 mg ER or 15 and 30 mg IR over-encapsulated oral tablets

DRUG

Placebo capsule

Oral placebo capsules matching the over-encapsulated morphine sulfate and oxycodone tablets

Trial Locations (3)

CRI Lifetree, Philadelphia

Vince and Associates Clinical Research, Inc., Overland Park

CRI Lifetree (Lifetree Clinical Research), Salt Lake City